Correlation Between Cannabis Strategic and Cannara Biotech

Can any of the company-specific risk be diversified away by investing in both Cannabis Strategic and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabis Strategic and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannabis Strategic Ventures and Cannara Biotech, you can compare the effects of market volatilities on Cannabis Strategic and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabis Strategic with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabis Strategic and Cannara Biotech.

Diversification Opportunities for Cannabis Strategic and Cannara Biotech

0.0

Correlation Coefficient

Cannabis Strategic  Cannara Biotech

Pay attention - limited upside

The 3 months correlation between Cannabis and Cannara is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cannabis Strategic Ventures and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Cannabis Strategic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabis Strategic Ventures are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Cannabis Strategic i.e., Cannabis Strategic and Cannara Biotech go up and down completely randomly.

Pair Corralation between Cannabis Strategic and Cannara Biotech

If you would invest  53.00  in Cannara Biotech on December 30, 2024 and sell it today you would earn a total of  40.00  from holding Cannara Biotech or generate 75.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cannabis Strategic Ventures  vs.  Cannara Biotech

Cannabis Strategic

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cannabis Strategic Ventures has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Cannabis Strategic is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Cannara Biotech

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cannabis Strategic and Cannara Biotech

The main advantage of trading using opposite Cannabis Strategic and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabis Strategic position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.

The idea behind Cannabis Strategic Ventures and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.